Roffman Miller Associates Inc Gsk PLC Transaction History

Roffman Miller Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$38.11 - $42.99 $254,651 - $287,259	-6,682 Closed	0 $0
Q2 2020 Nov 06, 2020	BUY	$37.87 - $43.58 $253,047 - $291,201	6,682 New	6,682 $277,000
Q3 2019 Nov 04, 2019	SELL	$40.46 - $43.52 $249,597 - $268,474	-6,169 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$39.4 - $42.7 $51,259 - $55,552	1,301 Added 26.73%	6,169 $247,000
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $187,758 - $207,814	4,868 New	4,868 $204,000
Q4 2018 Feb 11, 2019	SELL	$37.8 - $42.69 $214,628 - $242,393	-5,678 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$39.75 - $42.69 $39 - $42	1 Added 0.02%	5,678 $228,000
Q2 2018 Aug 07, 2018	BUY	$39.61 - $42.76 $79 - $85	2 Added 0.04%	5,677 $229,000
Q1 2018 May 01, 2018	SELL	$36.18 - $40.15 $27,388 - $30,393	-757 Reduced 11.77%	5,675 $222,000
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $3,993 - $4,734	-113 Reduced 1.73%	6,432 $228,000
Q3 2017 Nov 03, 2017	BUY	$39.44 - $41.55 $258,134 - $271,944	6,545	6,545 $266,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Roffman Miller Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Roffman Miller Associates Inc with notifications on news.